Doctors are one step closer to having a risk biomarker to alert them to which of their pediatric stem cell transplant patients are likely to experience a potentially deadly side effect called sinusoidal obstruction syndrome ...
May 22, 2023
0
41
In stem cell transplants, which are used for the treatment of leukemia, the patient's hematopoietic system is eliminated and replaced by hematopoietic cells from donors. Even though the amount of complications occurring in ...
Feb 9, 2023
0
53
Acute Graft-versus-host disease (GvHD) is a life-threatening complication after leukemia treatment with allogeneic stem cell transplantation (i.e., the transplantation of cells from another person). GvHD occurs when the transplanted ...
Jan 17, 2023
0
52
Posoleucel, an investigational allogeneic off-the-shelf T-cell therapy that simultaneously targets six different viruses, demonstrated promising antiviral efficacy and safety in a phase II study of patients who had undergone ...
Jan 11, 2023
0
40
In the six decades since blood and marrow transplantation was used to treat patients with blood cancers, this once experimental treatment has become a vital cancer-fighting tool. Mayo Clinic in Rochester, Minnesota, is celebrating ...
Oct 11, 2022
0
51
Researchers at Baylor College of Medicine and collaborating institutions have engineered immune cells to control two major life-threatening complications, namely graft-vs-host disease (GvHD) and cancer relapse, which typically ...
Sep 27, 2022
0
59
